HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Trolox down-regulates transforming growth factor-beta and prevents experimental cirrhosis.

Abstract
Cirrhosis is a very common disease and its treatment is limited due to lack of effective drugs. Some studies indicate that this disease is associated with oxidative stress. Therefore, we decided to study the effect of trolox, an effective antioxidant, on experimental cirrhosis. Cirrhosis was induced by CCl4 administration (0.4 g/kg, intraperitoneally, three times per week, for 8 weeks) to Wistar male rats. Trolox was administered daily (50 mg/kg, orally). Fibrosis was assessed histologically and by measuring liver hydroxyproline content. Glutathione, lipid peroxidation and glycogen were measured in liver; serum markers of liver damage were also quantified. Transforming growth factor-beta (TGF-beta) was determined by Western blot and quantified densitometrically. Alkaline phosphatase, gamma-glutamyl transpeptidase and alanine aminotransferase increased in the group receiving CCl4; trolox completely or partially prevented these alterations. Glycogen was almost depleted by CCl4 but was partially preserved by trolox. Lipid peroxidation increased while glutathione decreased by CCl4 administration; trolox corrected both effects. Histology showed thick bands of collagen, necrosis and distortion of the hepatic parenchyma in the CCl4 group, such effects were prevented by trolox. Hydroxyproline content increased 5-fold by CCl4, while the group receiving both CCl4 and trolox showed no significant difference compared to the control group. CCl4 increased 3-fold TGF-beta, while trolox completely prevented this increase. We found that trolox effectively prevented cirrhosis induced with CCl4 in the rat. Our results suggest that the beneficial effects of trolox may be associated to its antioxidant properties and to its ability to reduce the profibrogenic cytokine TGF-beta expression.
AuthorsMarina Galicia-Moreno, Adriana Rodríguez-Rivera, Karina Reyes-Gordillo, José Segovia, Mineko Shibayama, Víctor Tsutsumi, Paula Vergara, Mario G Moreno, Eduardo Fernández-Martínez, Víctor M Pérez-Alvarez, Pablo Muriel
JournalBasic & clinical pharmacology & toxicology (Basic Clin Pharmacol Toxicol) Vol. 103 Issue 5 Pg. 476-81 (Nov 2008) ISSN: 1742-7843 [Electronic] England
PMID18811677 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antioxidants
  • Chromans
  • Transforming Growth Factor beta
  • Glycogen
  • Carbon Tetrachloride
  • gamma-Glutamyltransferase
  • Alanine Transaminase
  • Alkaline Phosphatase
  • Glutathione
  • Hydroxyproline
  • 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
Topics
  • Alanine Transaminase (blood)
  • Alkaline Phosphatase (blood)
  • Animals
  • Antioxidants (pharmacology)
  • Blotting, Western
  • Carbon Tetrachloride
  • Chromans (pharmacology)
  • Down-Regulation (drug effects)
  • Glutathione (drug effects, metabolism)
  • Glycogen (metabolism)
  • Hydroxyproline (drug effects, metabolism)
  • Lipid Peroxidation (drug effects)
  • Liver Cirrhosis, Experimental (physiopathology, prevention & control)
  • Male
  • Rats
  • Rats, Wistar
  • Transforming Growth Factor beta (drug effects, metabolism)
  • gamma-Glutamyltransferase (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: